•   
  •   

World Scientists, including Fauci, are facing off over whether to delay 2nd vaccine doses. Here's why the risk of more mutations from delaying shots may ultimately be worth it.

09:09  10 february  2021
09:09  10 february  2021 Source:   businessinsider.com.au

The Vaccine Line Is Illogical

  The Vaccine Line Is Illogical Medicines should be distributed equitably, but the neediest are seldom at the front of the line. Every state and every health-care provider has protocols that supposedly direct the first coronavirus vaccines to the people who need them most. Communities are moving down their list at different speeds and in different orders, but the definition of who goes next is being interpreted broadly.

Scientists , including Fauci , are facing off over whether to delay 2 nd vaccine doses . Here ' s why the risk of more mutations from delaying shots may ultimately be worth it . The risk of more coronavirus mutations could be the price we have to pay. Visit the Business section of Insider for more stories. Experts are split on whether governments should delay the second doses of coronavirus vaccines to ensure more people get a first shot . Countries must decide what to do with their limited vaccine stock: Do they immunize more people with a first dose of a two- dose shot , which doesn't

Scientists , including Fauci , are facing off over whether to delay 2 nd vaccine doses . Here ' s why the risk of more mutations from delaying shots may ultimately be worth it . Experts are split on whether to delay the second dose of COVID-19 vaccines to get more people immunized. Prioritizing first doses means that more vulnerable people get some protection against coronavirus, which could save lives. The risk of more coronavirus mutations could be the price we have to pay. Read the full analysis from Dr. Catherine Schuster-Bruce here >>. © Provided by Business Insider ICU nurse

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, preparing to receive his first dose of a COVID-19 vaccine at the National Institutes of Health on December 22 in Bethesda, Maryland. Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, preparing to receive his first dose of a COVID-19 vaccine at the National Institutes of Health on December 22 in Bethesda, Maryland.
  • Experts are split on whether to delay the second dose of COVID-19 vaccines to get more people immunized.
  • Prioritising first doses means that more vulnerable people get some protection against coronavirus, which could save lives.
  • The risk of more coronavirus mutations could be the price we have to pay.
  • Visit the Business section of Insider for more stories.

Experts are split on whether governments should delay the second doses of coronavirus vaccines to ensure more people get a first shot.

COVID-19 Vaccine Developers Ask the SEC to Help Keep the Secret of How They Set Prices

  COVID-19 Vaccine Developers Ask the SEC to Help Keep the Secret of How They Set Prices Pfizer, Johnson & Johnson and other drug companies are working to block votes on shareholder resolutions that would force the companies to disclose how government funding affects their drug pricing.Now, two of the companies awarded those contracts—Pfizer and Johnson & Johnson—are trying to prevent shareholders from voting on resolutions to require the companies to disclose information about the impact of government funding on vaccine access.

(CNN) Delaying second doses of the Covid-19 vaccine so that as many Americans as possible can get the first dose is "not necessarily" what Dr. Anthony Fauci recommends, he said Wednesday. Fauci told ABC' s George Stephanopoulos it looks like there will be a much steadier supply of vaccines coming The team of researchers at Imperial College London used cell phone location data covering more than 10 million people and publicly available information on the spread of the virus to calculate which age groups were most responsible for the spread of the virus across most of the United States.

The next day it went viral all over the world. On September 6 the WITS suddenly changed the How could Fauci guarantee a surprise outbreak to happen during the first term of the Trump ‘The United Nations ( including WHO) conducts at least two system-wide training and simulation exercises It worries many scientists : It is a group of Chinese researchers attaching a protein taken from bats to

Countries must decide what to do with their limited vaccine stock: Do they immunize more people with a first dose of a two-dose shot, which doesn't give them full protection against the coronavirus, or do they hold back doses so that more people complete the vaccine course? Central to the debate is how to minimise the risk from coronavirus variants that are more contagious than the original virus, and threaten to make vaccines less effective.

So far, all authorised COVID-19 shots in the world are two-dose vaccines. Some experts, including Dr. Anthony Fauci, the leading infectious disease expert in the US, fear that delaying second doses risks variants spreading faster. This is because a weaker immune response, from one dose instead of the full two, could nurture variants with mutations that help them survive, they say.

Health chief defends AstraZeneca vaccine as some question Australia's COVID-19 vaccine strategy

  Health chief defends AstraZeneca vaccine as some question Australia's COVID-19 vaccine strategy Australia is relying on Pfizer and AstraZeneca vaccines to protect its citizens from COVID-19 but some believe it was a mistake to bypass other leading candidates such as Moderna and they want to know why, write Marty McCarthy and Nadia DalyThe criticism prompted the nation's former chief medical officer, now head of the Department of Health, Professor Brendan Murphy, to defend the AstraZeneca vaccine, telling 7.30 he would be "very pleased to have it".

Public health officials and scientists expect to know whether at least one of the numerous potential Covid-19 vaccines in development is safe and effective by the end of December or early next year, the director of the National Institute of Allergy and Infectious Diseases said during a live Q&A with The Washington Post. " It is likely that at the beginning of next year we would have tens of millions of doses available," Fauci said, adding that some drugmakers have predicted more doses than that. "I think as we get into 2021, several months in, that you would have vaccines that would be widely available."

Scientists are hoping for a coronavirus vaccine that is at least 75% effective, but 50% or 60% effective would be acceptable, too, Fauci , director of the National Institute of Allergy and Infectious Diseases, said during a Q&A with the Brown University School of Public Health. "The chances of it being 98 The Food and Drug Administration has said it would authorize a coronavirus vaccine so long as it is safe and at least 50% effective. Dr. Stephen Hahn, the FDA' s commissioner, said last month that the vaccine or vaccines that end up getting authorized will prove to be more than 50% effective, but it ' s

Variants are a significant concern â€" but for now, a theoretical one, as it has not yet been demonstrated that delaying second shots promotes variants.

On the other hand, the 2.3 million deaths worldwide from COVID-19 are proof that the risk from coronavirus is deadly and immediate. Getting people some immunity from the first shot might, therefore, be a better focus. Some experts are arguing just that: Immunizing as many people as possible protects more vulnerable people from dying, they say. It also could mean the virus spreads less, giving it fewer chances to multiply and mutate.

UK delays second doses by up to 12 weeks

The UK government pioneered the strategy of delaying the second COVID-19 vaccine dose on December 31, aiming to give some immunity to as many people as possible amid surging numbers of hospitalizations caused by a more contagious variant, called B.1.1.7.

Solidarity no more. Vaccine nationalism separates the world’s haves from have-nots

  Solidarity no more. Vaccine nationalism separates the world’s haves from have-nots Rich countries have way more COVID-19 vaccine doses than they need as poor countries scramble to secure enough.The ship has sailed on vaccine equity. Rich countries have preordered enough COVID-19 vaccines to inoculate their populations multiple times. The World Health Organisation’s vision of equal access through COVAX is at risk of failing and mass immunisation in low-income countries isn’t likely until 2024 — if at all.

Dr. Anthony Fauci , the epidemiologist revered almost religiously as a hero by mainstream media outlets and Democrat politicians, has admitted that he lied to Americans to manipulate their acceptance of a new Covid-19 vaccine . When pressed on the moving target in a New York Times interview, Fauci said he purposely revised his estimates gradually. The newspaper, which posted the article on Thursday, said Fauci changed his answers partly based on “science” and partly on his hunch “that the country is finally ready to hear what he really thinks.”

Dr. Fauci is giving the country a bit of hope with his latest vaccine estimates. After months and months of devastating news concerning the coronavirus pandemic, experts offered a bit of a silver lining over the weekend. Anthony Fauci , the nation’ s highest-ranking infectious-diseases doctor, said that although the demand for vaccinations “clearly outstrips supply right now,” the situation’ s expected to I think it ’ s possible that by April, supply could outstrip demand. We should start to focus now on that challenge. By the end of March we’ll have put more than 250M doses into the market, assuming J&J gets authorized.

Brits can get the second dose of the COVID-19 vaccines authorised in the country â€" one from Pfizer-BioNTech, one from AstraZeneca-Oxford â€" up to 12 weeks after the first dose. The second dose must be the same vaccine.

Dr. Michael Osterholm, a former COVID-19 advisor for President Joe Biden, has said that the US should follow a similar model, prioritising the first dose and delaying the second. This would "reduce serious illness and death" that could occur in the weeks ahead due to coronavirus variants. The variant first found the UK, B.1.1.7, has spread to the US and the CDC predicts it will become the most common coronavirus variant by March.

Michael Osterholm wearing a suit and tie: Dr. Michael Osterholm, the director of the Centre for Infectious Disease Research and Policy at the University of Minnesota, during an appearance on NBC News' 'Meet the Press' on October 18. Dr. Michael Osterholm, the director of the Centre for Infectious Disease Research and Policy at the University of Minnesota, during an appearance on NBC News' 'Meet the Press' on October 18.

The Centres for Disease Control and Prevention (CDC) has recommended the second dose of the COVID-19 shots from Moderna or Pfizer, the two authorised in the country, should be given at the intervals tested in trials â€"Pfizer's and Moderna's shots were tested at 21 days and 28 days respectively, and were roughly 95% effective at preventing symptomatic COVID-19. But in "exceptional circumstances," such as when people have forgotten which dose they have received, it says second shots can be given up to six weeks following the first dose.

Israel outpaced the world in vaccinations. Now it’s seeing the results.

  Israel outpaced the world in vaccinations. Now it’s seeing the results. There’s still a long way to go, but also a reason for hope.Data suggests that the pandemic is starting to slow in Israel. Infections and the number of seriously ill people are declining, particularly among those over 60, one of the groups targeted in the early rollout of the vaccination campaign.

The World Health Organisation has also recommended a six week gap "in exceptional circumstances," such as a vaccine shortage. The WHO said there is some clinical data that Pfizer's vaccine provides some protection against COVID-19 for up to six weeks from the first dose, so the guidance gives countries leeway to maximise the number of people benefiting from the first vaccine dose.

Many experts oppose delaying second doses

But Fauci, President Joe Biden's chief medical adviser, said Sunday that scientific data favours prioritising both doses over a single shot. Fauci also said in January that delaying the second dose could "immunologically select" for virus variants. "It may not be the case, but it gets risky," he said, without elaborating.

South Africa's most senior vaccine expert, Professor Barry Schoub, said January 7 that the coronavirus variants, including one found in South Africa, are more transmissible, which "would be a motivation to go for the double dose as much as you can." The variant spreading in South Africa has been shown in lab-studies to evade antibodies produced by the body, but researchers have suggested that higher levels of antibody can still fight against it.

Professor Lawrence Young, a virologist at the University of Warwick, told Insider that the longer you leave it between doses, "the more people are likely to get infected."

The Pandemic Can End Without Herd Immunity

  The Pandemic Can End Without Herd Immunity The new variants are rewriting the pandemic’s end—but it can still end.For COVID-19, the herd-immunity threshold is estimated to be between 60 and 90 percent. That’s the proportion of people who need to have immunity either from vaccination or from prior infection. In the U.S., the countdown to when enough people are vaccinated to reach herd immunity has already begun.

"They might not get sick but they could develop vaccine resistant strains and drive further evolution of the virus," he said.

However, the risks from delaying are uncertain

The UK's top scientist on January 5 called this a "real worry but quite a small real worry." Professor Chris Whitty, the UK chief medical officer, said that it was a "balance of risk" between getting more people immunized versus encouraging further mutations.

Professor Jonathan Stoye, an eminent virologist at the Francis Crick Institute told Insider that there was a "danger" of more mutations happening with delaying the second dose â€" but that we don't know how big the danger is. It is not a question of the number of mutations, but what type of mutations that get selected for, Stoye said. "We get a lot of mutations anyway."

The British approach of delaying the second dose could be especially advantageous for the COVID-19 vaccine co-developed by AstraZeneca and the University of Oxford, which uses an inactivated chimpanzee virus to stimulate an immune response, because trials have indicated a longer gap could even produce a better immune response.

Delaying the second dose of mRNA-based COVID-19 vaccines, which use a genetic code to produce an immune response, is more controversial because mRNA vaccines use groundbreaking technology, so we don't know how well they work when the second dose is delayed. Moderna and Pfizer's shots are mRNA-based. A small study in Israel, which came with caveats, has shown the single dose of Pfizer's shot was less effective than hoped.

Stoye and Young both told Insider that, overall, they agreed with Whitty that the risk of mutations was a trade-off.

Stoye said that the UK's approach wasn't foolish, as long as people get their second dose.

The most important thing is to protect vulnerable people from getting sick and dying, Young said. "Even if they're getting partial immunity, that should be enough."

Fauci: There's evidence COVID-19 vaccines don't just protect you — they may stop you spreading the virus to others, too .
Dr. Fauci is touting some of the first evidence that vaccines can help stop the spread of COVID-19. The hunch hinges on 2 new studies, which suggest vaccinated people don't spread the coronavirus well, even if they do get sick. Getting vaccinated, Fauci said, is "not only good for you," it can protect others too. Visit the Business section of Insider for more stories. Dr. Anthony Fauci says there's fresh evidence that a COVID-19 vaccine may not just protect the people who get it, it could also protect others who they come in contact with.

usr: 0
This is interesting!